BanColombia

Grupo Cibest SA is assigned a 3-star quantitative star rating, reflecting our opinion that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a 7% premium over our quantitative fair value estimate of $86.39 per share; however, this estimate should be taken with a pinch of salt due to its high uncertainty rating.

The firm's liquidity undermines our fair value estimate. Excessive liquidity may suggest inefficient capital use or limited investment opportunities. Reflecting the firm's liquidity is its median trading volume over the past 60 days, which sits in the top 45% compared with global peers. High trading volumes could indicate a sharp change in business model or a new growth trajectory of the business. We believe this is a sign that shares could be expensive.

Conversely, the firm's profitability is reassuring. Highly profitable companies are often more resilient in recessions and are likely to generate stronger future cash flows for shareholders. The firm's earnings yield of 8.2%, for example, ranks in the top 30% compared with peers globally. This suggests that it is generating substantial earnings relative to its share price, which, despite our unfavorable price/fair value ratio, is a positive attribute.

In addition to the aforementioned drivers, our model considers momentum as part of its comprehensive analysis. This share class has outperformed the broader universe over the past year. This outperformance may signify a bull trap, in light of other detractors from our model.

With its quantitative economic moat rating of none, we do not expect this company to materially outearn its cost of capital in the long run. However, its financial health score is strong, suggesting that the company should be well positioned to weather tough times.